Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Johnson & Johnson (JNJ)

178.58   -0.3 (-0.17%) 12-05 12:58
Open: 178.36 Pre. Close: 178.88
High: 179.36 Low: 178.01
Volume: 2,374,145 Market Cap: 466,894(M)

Technical analysis

as of: 2022-12-05 12:50:23 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 210.18     One year: 245.49
Support: Support1: 171.83    Support2: 166.82
Resistance: Resistance1: 179.94    Resistance2: 210.18
Pivot: 176.22
Moving Average: MA(5): 178.05     MA(20): 175.32
MA(100): 169.21     MA(250): 172.08
MACD: MACD(12,26): 2.2     Signal(9): 2.1
Stochastic oscillator: %K(14,3): 89.5     %D(3): 91.2
RSI: RSI(14): 64.7
52-week: High: 186.69  Low: 155.72
Average Vol(K): 3-Month: 6,909 (K)  10-Days: 5,015 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ JNJ ] has closed below upper band by 22.3%. Bollinger Bands are 2.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 179.17 - 179.86 179.86 - 180.55
Low: 175.12 - 175.96 175.96 - 176.8
Close: 177.53 - 178.81 178.81 - 180.09

Company Description

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Headline News

Mon, 05 Dec 2022
Is Johnson & Johnson Stock A Better Pick Over Its Peer? - Forbes

Sat, 03 Dec 2022
J&J Says It Won't Make an Offer for Horizon Therapeutics - Bloomberg

Sat, 03 Dec 2022
Johnson & Johnson: Time To Buy Before The Split (NYSE:JNJ) - Seeking Alpha

Sat, 03 Dec 2022
Johnson & Johnson: Boring, But Worth In Your Portfolio (NYSE:JNJ) - Seeking Alpha

Wed, 30 Nov 2022
Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know - Nasdaq

Wed, 30 Nov 2022
Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board - Business Wire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. 2,630 (M)
Shares Float 2,630 (M)
% Held by Insiders 0.1 (%)
% Held by Institutions 70.6 (%)
Shares Short 11,230 (K)
Shares Short P.Month 14,140 (K)

Stock Financials

EPS 5.65
EPS Est Next Qtl 1.99
EPS Est This Year 7.28
EPS Est Next Year 7.84
Book Value (p.s.) 25.01
Profit Margin (%) 19.9
Operating Margin (%) 25.5
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 1.8
Gross Profit (p.s.) 24.34
Sales Per Share 36.51
EBITDA (p.s.) 12.03
Qtrly Earnings Growth 22.2
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 31.55
PEG Ratio 4.4
Price to Book value 7.14
Price to Sales 4.89
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2022-03-07
Ex-Dividend Date 2022-02-17
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.